fr

EN DE

fr

EN DE

Publications

2108 PUBLICATIONS - effacer la recherche

ANNÉE

JOURNAL

PREMIER AUTEUR

TITRE

2022

Cancer immunology, immunotherapy : CII

Thibaudin M

Targeting PD-L1 and TIGIT could restore intratumoral CD8 T cell function in human colorectal cancer.

2022

Annals of oncology : official journal of the European Society for Medical Oncology

Basile D

Tumor budding is an independent prognostic factor in stage III colon cancer patients: A post-hoc analysis of the IDEA-France phase III trial (PRODIGE-GERCOR).

2022

The oncologist

Canton C

Impact of G-CSF Prophweylaxis on Chemotherapy Dose-Intensity, Link Between Dose-Intensity and Survival in Patients with Metastatic Pancreatic Adenocarcinoma.

2022

Advanced materials (Deerfield Beach, Fla.)

Mittelheisser V

Optimal Physicochemical Properties of Antibody-Nanoparticle Conjugates for Improved Tumor Targeting.

2022

Journal of neuroendocrinology

Deguelte S

Concept of reintervention with thorough lymphadenectomy after suboptimal resection of small-intestine neuroendocrine neoplasms: A multicentre preliminary study.

2022

Cancers

Nazon C

Together Intra-Tumor Hypoxia and Macrophagic Immunity Are Driven Worst Outcome in Pediatric High-Grade Osteosarcomas.

2022

The oncologist

Gantzer J

Immune-Desert Tumor Microenvironment in Thoracic SMARCA4-Deficient Undifferentiated Tumors with Limited Efficacy of Immune Checkpoint Inhibitors.

2022

British journal of haematology

Baumelou M

Early achievement of measurable residual disease negativity in the treatment of multiple myeloma as predictor of outcome.

2022

Breast (Edinburgh, Scotland)

Moinard-Butot F

Efficacy of trastuzumab emtansine (T-DM1) and lapatinib after dual HER2 inhibition with trastuzumab and pertuzumab in patient with metastatic breast cancer: Retrospective data from a French multicenter real-life cohort.

2022

Cardiovascular and interventional radiology

Rossi J

Safety and Oncologic Outcomes of Percutaneous Cryoablation of Renal Cell Carcinoma Recurrences in the Ipsilateral Kidney Following Partial Nephrectomy.